| Surgery Name | Cost | Room | Hospitalization |
|---|---|---|---|
| Juvenile nasopharyngeal angiofibroma | $2746 | Single | Patient - 3 days stay in a single room. |
🇮🇳 Medical Package — India
World-class treatment • NABH & JCI Accredited Hospitals • Save up to 80% vs USA/UK
Angiofibroma is a benign (noncancerous) nasal cavity tumor that almost exclusively affects adolescent boys. It also may be referred to as juvenile nasopharyngeal angiofibroma (JNA). The age range for this disease is 7 to 19 years old, with most people being diagnosed between 10 and 19 years old. Juvenile nasopharyngeal angiofibroma is the most common benign tumor of the nasopharynx, but has a relatively low incidence. It accounts for only 0.5 percent of all head and neck tumors.
Symptoms
The most common symptoms of angiofibroma include:
Some people also may develop facial deformities or abnormalities, including:
Risks of Angiofibroma
The most common treatment for angiofibroma is surgery. Angiofibromas may be approached directly using the Endoscopic Endonasal Approach (EEA). This state-of-the-art, minimally invasive approach allows surgeons to access the tumor through the natural corridor of the nose, without making an open incision. Surgeons then remove the angiofibroma through the nose and nasal cavities.
EEA offers the benefits of no incisions to heal, no disfigurement, and a faster recovery time. If you need complementary treatments, such as radiation, those therapies can begin soon after EEA surgery. Prior to surgery, an angiogram may be performed. This imaging test uses x-rays to view blood vessels that have been injected with a contrasting dye, to allow for embolization of the tumor. Embolization involves cutting off the blood supply to the tumor. It significantly reduces blood loss during surgery and tumor removal.
Radiation therapy may be used for people with angiofibroma tumors that have extended into the cranial cavity, can't be reached safely by surgery, or have returned after previous treatment.
Hormonal flutamide, which blocks testosterone receptors, has been shown to reduce tumor size effectively. The use of this medication is restricted to those enrolled in clinical trials.
If you have any related query, you can send us your report on below mention email address or you can call us or whatsApp for any second opinion.
Video/tele consultation also available.
E-mail address- query@satyughealthcare.com
Phone number- +91888-242-4372, +91991-065-5125
Free Medical Opinion
Expert review in 48 hours
Best Surgeon
Top specialists in India
Hospital Booking
NABH / JCI accredited
Visa Assistance
Invitation letter provided
Airport Transfer
Safe pickup & drop
Tele-Consultation
Video consult before travel
Hotel Booking
Near hospital, affordable
Multilingual Support
Arabic, French, English
📞 Get Started Today — It Is Free
Send your medical reports and get a free expert opinion within 48 hours. Our coordinators speak Arabic, French and English.
They are a cosmetic nuisance for some patients, but are not dangerous and cannot turn into skin cancer. Angiofibromas can be sa